Nimodipine
Nimodipine Capsules For Oral Use
Approved
Approval ID
18855589-5063-484f-a064-cb1110833302
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Dec 13, 2023
Manufacturers
FDA
McKesson Corporation dba SKY Packaging
DUNS: 140529962
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Nimodipine
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code63739-797
Application NumberANDA090103
Product Classification
M
Marketing Category
C73584
G
Generic Name
Nimodipine
Product Specifications
Route of AdministrationORAL
Effective DateDecember 13, 2023
FDA Product Classification
INGREDIENTS (8)
GELATIN, UNSPECIFIEDInactive
Code: 2G86QN327L
Classification: IACT
GLYCERINInactive
Code: PDC6A3C0OX
Classification: IACT
PEPPERMINT OILInactive
Code: AV092KU4JH
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
POLYETHYLENE GLYCOL 400Inactive
Code: B697894SGQ
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
FERROSOFERRIC OXIDEInactive
Code: XM0M87F357
Classification: IACT
NIMODIPINEActive
Quantity: 30 mg in 1 1
Code: 57WA9QZ5WH
Classification: ACTIB